Inhibition on human liver cytochrome P450 3A4 by constituents of fennel
Dr. Oesterheld’s Comment: Although clinicians may be well aware of the potential of grapefruit juice to be an inhibitor of CYP3A4, only a few may be aware of the possibility of other CYP-based food- drug interactions. In this study, fennel, an herb and alternate drug is shown to be a modest CYP3A4 inhibitor. Since its inhibition is mechanism-based, the recovery from inhibition may take a few days since new CYP will need to be manufactured and as a result, it is more likely to cause drug interactions. However, because the Ki is low (15), whether it actually is involved in invivo drug interactions is hard to say.
J Agric Food Chem. 2007 Dec 12;55(25):10162-7. Epub 2007 Nov 8.
Inhibition on human liver cytochrome P450 3A4 by constituents of fennel (Foeniculum vulgare): identification and characterization of a mechanism-based inactivator.
Subehan , Zaidi SF, Kadota S, Tezuka Y.Institute of Natural Medicine, University of Toyama, 2630- Sugitani, Toyama 930-0194, Japan.
Fennel, a seed of Foeniculum vulgare, is used as a culinary spice and traditional medicine. The methanolic extract of fennel showed a characteristic of mechanism-based inactivation on erythromycin N-demethylation mediated by human liver microsomal cytochrome P450 3A4 (CYP3A4). The present study was conducted to identify the fennel constituent having the inhibition. Thirteen compounds have been isolated from a methanol extract of fennel and tested for their inhibition on CYP3A4. Among them, 5-methoxypsoralen (5-MOP) showed the strongest inhibition with an IC50 value of 18.3 microM and a mixed type of inhibition. In addition, with the preincubation time of 20 min only 5-MOP showed preincubation time dependency; the IC50 value decreased from 18.3 microM with a preincubation time of 0 min to 4.6 microM with a preincubation time of 20 min. Further investigation on 5-MOP showed the characteristics of time-dependent inhibition, requirement of NADPH, lack of protecting effect of nucleophiles, and recovery of CYP3A4 activity by the competitive inhibitor. This result suggests that the inhibitory activity of CYP3A4 by 5-MOP was a mechanism-based inactivation. The kinetic parameter for mechanism-based inactivation was characterized by a KI value of 15.0 microM and a kinact value of 0.098 min(-1). PMID: 17988092
Take a Risk Assessment
Simply enter the medications you’re currently on or plan to take. Click “Get Results” to see if your regimen puts you at risk for an adverse drug reaction.
YOUR GENELEX RISK ASSESSMENT RESULTS: